Regenxbio (RGNX) EBIT Margin Growth (1y) (2015 - 2025)
Regenxbio (RGNX) EBIT Margin Growth (1y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Regenxbio |
342.96 Mn |
112.89 Mn |
- |
5,216.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
5,216.00 |
| Sep 30, 2025 |
8,028.00 |
| Jun 30, 2025 |
-4,492.00 |
| Mar 31, 2025 |
42,243.00 |
| Dec 31, 2024 |
4,554.00 |
| Sep 30, 2024 |
-3,189.00 |
| Jun 30, 2024 |
11,462.00 |
| Mar 31, 2024 |
-6,312.00 |
| Dec 31, 2023 |
-10,338.00 |
| Sep 30, 2023 |
4,331.00 |
| Jun 30, 2023 |
-17,443.00 |
| Mar 31, 2023 |
-2,375.00 |
| Dec 31, 2022 |
-26,297.00 |
| Sep 30, 2022 |
-8,161.00 |
| Jun 30, 2022 |
4,548.00 |
| Mar 31, 2022 |
-8,871.00 |
| Dec 31, 2021 |
32,884.00 |
| Sep 30, 2021 |
-20,046.00 |
| Jun 30, 2021 |
1,551.00 |
| Mar 31, 2021 |
-1,955.00 |
